News Focus
News Focus
Followers 20
Posts 2314
Boards Moderated 0
Alias Born 12/13/2009

Re: Steady_T post# 368466

Monday, 08/01/2022 3:42:41 AM

Monday, August 01, 2022 3:42:41 AM

Post# of 517007

You seem to have missed the fact that Anavex has multiple shots on goal.



Nope--haven't missed that or anything else. It's the multiple shots on goal that brought me into Anavex. In fact, I am counting on Anavex to ultimately rescue me if SAVA fails.

"A mediocre outcome is possible. Even then the SOC is so low that a mediocre outcome will likely result in an approval even if 2-73 is not the wonderful AD drug that is hoped."

I'm pretty comfortable you're not suggesting that trial results below stat sig could result in approval (without regard to the low SOC) because anything sort of stat sign on primary endpoints would certainly not be a "mediocre outcome". I believe that would considered an outright trial failure. Please correct me if you think that is not the case.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News